Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) after high-dose conditioning regimens imposes prohibitively high risks of morbidity and mortality for patients with high-risk acute myeloid leukemia (AML) who are older or have comorbid conditions. Here, we examined outcomes after nonmyelo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gyurkocza, Boglarka, Storb, Rainer, Storer, Barry E., Chauncey, Thomas R., Lange, Thoralf, Shizuru, Judith A., Langston, Amelia A., Pulsipher, Michael A., Bredeson, Christopher N., Maziarz, Richard T., Bruno, Benedetto, Petersen, Finn B., Maris, Michael B., Agura, Edward, Yeager, Andrew, Bethge, Wolfgang, Sahebi, Firoozeh, Appelbaum, Frederick R., Maloney, David G., Sandmaier, Brenda M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2010
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903320/
https://ncbi.nlm.nih.gov/pubmed/20439626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1460
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak